Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

The Oncologist, 2026
Phase 1/2 study of INCAGN01876, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, plus immunotherapy for advanced cancers

Hamid O., Forget F., Johnson M. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Nature Aging, 2026
Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset

Yu S., Chen C., Feng J. et al.

Olink Explore 3072/384Metabolic DiseasesHepatologyPatient StratificationPlasma

Biological Psychiatry Global Open Science, 2026
Smoking interacts with APOE ε4 to influence dementia: evidence from UK biobank and validation by meta-analysis of longitudinal studies

Cong Y., Wang Y., Huang L. et al.

Olink Explore 3072/384NeurologyEnvironmental Health & ToxicologyPathophysiologyPlasma

Journal of Immunology Research, 2026
Cytokine Changes With Effective Drug Therapy for Juvenile Myasthenia Gravis

Geng Y., Liu P., Jin M. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

BMC Cancer, 2026
Exploration of plasma proteomic landscapes using Olink Reveal technology to identify biomarkers for early-stage/localized gastric cancer

Ding S., Li X., Dong X. et al.

RevealOncologyPatient StratificationPlasma

International Journal of Women's Health, 2026
Causal Effects of Circulating Inflammatory Proteins on Postmenopausal Atrophic Vaginitis in European Populations: A Mendelian Randomization Study with Transcriptomic Validation

Hu X., Ruan S., Zhong T. et al.

Olink Target 96EndocrinologyGynecologyPathophysiologyPlasma

Theranostics, 2026
Metabolic-Immune Reprogramming via CuZnS@BSA Nanoregulators to Overcome Resistance in Triple-Negative Breast Cancer

Yang J., Li Q., Zhao P. et al.

Olink Target 48 MouseOncologyPathophysiologyMouse Serum

Nature Medicine, 2026
Longitudinal plasma proteomics predict phenoconversion to clinically manifest ALS

Ran X., Wuu J., Qin Z. et al.

Olink Explore 3072/384Olink Explore HTNeurologyPatient StratificationPlasma

Journal of Colloid and Interface Science, 2026
Introduction of optimized folate group modification on lipid-coated magnetic nanobeads enables targeting of folate receptor beta

Schaaf M., Offer S., Zhang H. et al.

Olink Target 96Respiratory DiseasesTechnical EvaluationCell Culture Supernatant

npj Genomic Medicine, 2026
Circulating cell-free RNA signatures associate with plaque calcification in advanced carotid atherosclerosis

Wei J., Lan T., Zhu Y. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Neurological Sciences, 2026
Proteome-wide Mendelian randomization identifies causal plasma proteins in frontotemporal dementia

Yao Y., Zou Q., Chen K.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

International Journal of Cardiology, 2026
Activation of the complement lectin pathway is associated with long-term cardiac dysfunction and incident heart failure in acute coronary syndrome patients

Zhong B., King B., Mares R. et al.

Olink Target 96CVDPatient StratificationPlasma

Allergy, 2026
Distinct Immunometabolic Profiles in Finnish and Russian Karelian Adolescents With Contrasting Allergy Risk

Fyhrquist N., Riskumäki M., Karisola P. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyCell Culture SupernatantSerum

Proteomes, 2026
Proteomic Mediators Linking Autoimmune Diseases to Major Adverse Cardiovascular Events: Insights from the UK Biobank

Huang J., Liu C., Sperling L. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesCVDPathophysiologyPatient StratificationPlasma

Nature Genetics, 2026
Nanoparticle-enriched mass spectrometry proteomics in British South Asians identifies links between genetic variants, plasma protein levels and disease risk

Pietzner M., Williamson A., Hunt K. et al.

Olink Explore HTWider Proteomics StudiesCross-platform ValidationPlasma

Immunity & Ageing, 2026
Reduced NK cell frequency in older patients with evolving fractures is linked to a distinct inflammatory cytokine profile

Moch J., Kappes J., Jauregui R. et al.

Olink Target 96AgingOrthopedicsPathophysiologyPlasma

Annals of the Rheumatic Diseases, 2026
CNS immune remodelling in SLE associated with anti-CD19 CAR-T therapy

Sun J., Hu X., Li W. et al.

Olink Target 96NeurologyPathophysiologyCSF

Nature Communications, 2026
Absent pleocytosis in infant viral central nervous system infections reflects lymphocyte depletion and cytokine activation

Mills C., Drummond H., Groves H. et al.

Olink Target 96NeurologyInfectious DiseasesPathophysiologyPlasma

Brain, Behavior, & Immunity - Health, 2026
Plasma proteomic profile of inflammatory depressive symptoms

Ängeby F., Ventorp F., Stiernborg M. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

Brain, Behavior, & Immunity - Health, 2026
Plasma proteomic profile of inflammatory depressive symptoms

Ängeby F., Ventorp F., Stiernborg M. et al.

Olink Target 96NeurologyPathophysiologyPlasma

4306 publications